Total Current Assets - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Portage Biotech Inc
Total Current Assets Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Total Current Assets
$5.2m
CAGR 3-Years
-45%
CAGR 5-Years
-2%
CAGR 10-Years
12%
Theratechnologies Inc
TSX:TH
Total Current Assets
$57.3m
CAGR 3-Years
-18%
CAGR 5-Years
-4%
CAGR 10-Years
15%
Repare Therapeutics Inc
NASDAQ:RPTX
Total Current Assets
$243.7m
CAGR 3-Years
-11%
CAGR 5-Years
83%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Current Assets
$409.7m
CAGR 3-Years
5%
CAGR 5-Years
24%
CAGR 10-Years
26%
Covalon Technologies Ltd
XTSX:COV
Total Current Assets
CA$23.3m
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
13%
Spectral Medical Inc
TSX:EDT
Total Current Assets
CA$9.1m
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

See Also

What is Portage Biotech Inc's Total Current Assets?
Total Current Assets
5.2m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Total Current Assets amounts to 5.2m USD.

What is Portage Biotech Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
12%

Over the last year, the Total Current Assets growth was -52%. The average annual Total Current Assets growth rates for Portage Biotech Inc have been -45% over the past three years , -2% over the past five years , and 12% over the past ten years .

Back to Top